🚨 AI News | TestingCatalog· @testingcatalog · X·· 2 小时前AI 评分62
AI 导读
OpenAI 宣布收购 Orchestra Bio，一个帮助生物制药团队协调复杂药物研发流程的平台。双方将基于 Rosalind（OpenAI 面向生命科学研究的 AI 模型和工具）整合运营，帮助新疗法更快惠及患者。作者评论称生命科学中的 AI 进展是 Anthropic、OpenAI 和 Google 共同的重点方向。
正文 · 原文
OpenAI ❤️ Orchestra Bio
OpenAI has acquired Orchestra Bio to work on Rosalind models and tools for life sciences research.
"Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."
AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：🚨 AI News | TestingCatalog · x.com